Document:

<PAGE>

                AGREEMENT to PURCHASE and USE T-HEXX CONCENTRATE
                                       and
                               T-HEXX(R) TRADEMARK

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-i
================================================================================

                AGREEMENT to PURCHASE and USE T-HEXX CONCENTRATE
                                       and
                                T-HEXX" TRADEMARK

TABLE OF CONTENTS

1. GRANT OF LICENSE..........................................................  1

2. OWNERSHIP OF MARKS........................................................  1

3. ADVERTISING COPY/LABELING.................................................  2

4. QUALITY MAINTENANCE.......................................................  2

5. FORM OF USE...............................................................  3

6. USE FEE...................................................................  3

7. INFRINGEMENT PROCEEDINGS..................................................  4

8. TERM......................................................................  4

9. TERMINATION OF LICENSE FOR NOT ABIDING BY MINIMUM PURCHASES...............  4

10. TERMINATION..............................................................  4

11. EFFECT OF TERMINATION....................................................  5

12. SUPPLY OF T-HEXX CONCENTRATE.............................................  5

13. PATENT LICENSE TO USE....................................................  6

14. INDEMNIFICATION AND INSURANCE............................................  6

15. FORCE MAJEURE
 .............................................................................  6

16. GENERAL PROVISIONS.......................................................  6
         a. Assignment.......................................................  7
         b. Entire Agreement.................................................  7
         c. Not a franchise..................................................  7

<PAGE>
T-HEXX" LICENSE and USE AGREEMENT                                        Page-ii
================================================================================

         d. Surviving Clauses................................................  7
         e. Waiver...........................................................  7
         f. Controlling Law and Place of Suit................................  7

Exhibit A....................................................................  9

Exhibit B.................................................................... 10

Exhibit C.................................................................... 11

Exhibit D.................................................................... 14

Exhibit E.................................................................... 15

Exhibit F.................................................................... 17

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-1
================================================================================

This Agreement entered into on the 1st day of January, 2001, between:

Hydromer, Inc. ("Hydromer"), a corporation organized and existing under the laws
of New Jersey, located at 35 Industrial Parkway, Branchburg, N.J., U.S.A

and

LHS Limited and LHS Holding Limited, English registration 2469440, dba
KLEENCARE, with its registered offices at Duke Ave., Stanley Green Cheadle
Hulme, Cheshire SK8 6RB. ("Kleencare").

Hydromer is the owner of the trademarks and service marks (the "Marks"), and
applications and registrations for the Marks, listed in Exhibit A. Kleencare
desires to use the Marks in connection with its business. In consideration of
the foregoing and of the mutual promises set forth in this agreement, the
parties agree as follows:

1. GRANT OF LICENSE

In consideration of US$_____ and other consideration herein, Hydromer grants to
Kleencare a non-exclusive, non-transferable license, without the right to
sub-license, to use the Marks in connection with the manufacture and sales of
the goods listed in Exhibit B within the sovereigns of:

                  Germany, France, Netherlands, Belgium, Luxembourg, United
                  Kingdom, Ireland, Austria, Switzerland.

Kleencare accepts the license subject to the following additional terms and
conditions.

2. OWNERSHIP OF MARKS

Kleencare acknowledges that Hydromer owns the Marks and agrees that it will do
nothing inconsistent with such ownership, including but not limited to selling
any product that competes with the goods or services in Exhibit B. All uses of
the Marks by Kleencare shall inure to the benefit of, and be on behalf of
Hydromer. Hydromer will provide any data which is then in existence to aid
Kleencare to register products carry the Marks appropriate governmental
authorities.

Nothing in this license shall give Kleencare any right, title, or interest in
the

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-2
================================================================================

Marks, other than the right to use the Marks in accordance with the terms of
this license. Kleencare will not attack the title of Hydromer to the Marks or
attack the validity of this license.

3. ADVERTISING COPY/LABELING

Hydromer at it's own expense will provide all advertising copy and creative
works in the English language (which Hydromer claims are copyrights of Hydromer)
to Kleencare. Kleencare shall not, without written permission, place
advertisements, develop sales material, communicate clinical results or
otherwise develop any communications to third parties relating to the Marks or
the goods/services on which the Marks are used including the labeling and labels
used on or with the goods and services. Kleencare will be allowed, upon the
written approval of Hydromer, to modify the copy with respect to the European
market. Kleencare will have the right to propose advertising copy for approval
by Hydromer Labeling and Advertising Guidelines in Exhibit E shall be followed.

Hydromer shall promptly review all proposed marketing and advertising material
received from Kleencare with 3 business days of receipt and provide Kleencare
with either an approval or requirements for changes.

4. QUALITY MAINTENANCE

The nature and quality of all services rendered and goods sold by Kleencare in
connection with the Marks shall conform to standards set by Hydromer. Standards
for product formulation and testing are attached as Exhibit C. Any changes in
the formulation and/or testing shall be on an amendment signed by both parties.

Hydromer will guarantee the physical and chemical stability of the T-Hexx
concentrate supplied to Kleencare. Kleencare guarantees not to modify the
finished product formulations without the expressed written approval of Hydromer
and further agrees to provide Hydromer with the results of any tests performed
on T-HEXX"ORO dip.

Kleencare will meet all quality aspects of the formulations made by Kleencare
and will permit reasonable inspection of Kleencare's operation. Kleencare will
supply Hydromer with specimens and test results for each batch of product which
carries the Marks with 14 working days on a reporting format attached as Exhibit
F or such other format IF approved in writing by Hydromer.

UNDER NO CIRCUMSTANCES WILL KLEENCARE RELEASE ANY BATCH OF T-HEXX PRODUCTS FOR
SALE UNTIL THE TESTS SET FORTH IN EXHIBIT C ARE COMPLETED BY KLEENCARE.

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-3
================================================================================

Until such release the batch(s) are to be quarantined. Any release of untested,
partially tested or inaccurately tested Product is a material breach of this
Agreement. Kleencare agrees that the safety and effectiveness of the T-HEXX
goods made by Kleencare are the sole responsibility of Kleencare, however
Hydromer has the right to take all reasonable steps to insure that its
trademarks are not tainted, clouded or diluted by a poor quality T-HEXX product.

Any recall of a T-HEXX product shall be done at the expense of Kleencare unless
the defect is caused by the T-HEXX concentrate supplied by Hydromer. The quality
of the T-HEXX concentrate shall be determined by the retained samples kept at
Hydromer.

KLEENCARE SHALL COMPLY WITH ALL APPLICABLE LAWS AND REGULATIONS AND OBTAIN ALL
APPROPRIATE GOVERNMENTAL APPROVALS PERTAINING TO THE MANUFACTURE, TESTING, SALE,
DISTRIBUTION, AND ADVERTISING OF GOODS AND SERVICES COVERED BY THIS LICENSE.

In the event that the quality of Kleencare's goods or services with which the
Marks are used falls below acceptable standards established by Hydromer or any
government within the territory, or Kleencare fails to submit samples and test
results to Hydromer for each batch, at the sole and exclusive judgment of
Hydromer, which shall be conclusive, Hydromer shall notify Kleencare in writing.
Kleencare shall cure any deficiency in quality within thirty (30) days of
receipt of such notice of deficiency from Hydromer. In the event that such
deficiency is not cured within thirty (30) days, Hydromer shall have the right
to terminate this agreement.

5. FORM OF USE

Kleencare will use the Marks only in the form and manner and with appropriate
legends as prescribed from time to time by Hydromer, and will not use any other
trademark or service mark in combination with any of the Marks without the prior
written approval of Hydromer.

6. USE FEE

Kleencare agrees to pay a use fee for all uses of the Marks pursuant to the rate
set forth in Exhibit D. The uses of the Marks and the payment of the use fee
must be received by Hydromer within 45 days after the end of any calendar
quarter. In the event Exhibit D contains minimum payments, said payments will be
so included.

7. INFRINGEMENT PROCEEDINGS

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-4
================================================================================

Kleencare agrees to notify Hydromer of any unauthorized use of the Marks by
others as soon as it comes to Kleencare's attention. Hydromer shall have the
right and discretion to bring infringement or unfair competition suit or
proceedings involving the Marks. In the event Hydromer fails to bring such suit
or proceeding, Kleencare at its cost, shall have the right to bring such suit or
proceedings after a 60 day written notice to Hydromer.

8. TERM

This agreement shall continue in full force unless sooner terminated as provided
for in this agreement.

9. TERMINATION OF LICENSE FOR NOT ABIDING BY MINIMUM PURCHASES

Starting with the quarter beginning January 1, 2001, and for each quarter
thereafter, the quarterly minimum purchases of T-Hexx concentrate shall be as
set forth in Exhibit D. ("the Minimum"). Hydromer reserves the unilateral right
to terminate this agreement if the Minimums are not met after a 15 day written
notice. Kleencare may nullify the effect of this notice if it pays an amount
computed by multiplying .75 times the shortfall in the quarterly minimum
purchase time the unit price + use fee. The shortfall shall be the actual
purchase in a quarter subtracted from the minimum purchase for the same quarter.

10. TERMINATION FOR OTHER REASONS

Either party shall have the right to terminate this agreement upon thirty (30)
days' written notice to Kleencare in the event of any affirmative act of
insolvency by the other party, or upon the appointment of any receiver or
trustee to take the possession of the properties of such other party, or upon
the winding up, sale, consolidation, merger, change of control or any other
sequestration by governmental authority of such other party.

In addition Hydromer shall have the right to terminate this agreement upon
thirty (30) days written notice if Kleencare attains a total receivable to
Hydromer in the amount over US$50,000 for more then 60 days for any product
purchased or use fee owed or upon breach of any of the provisions of this
agreement by Kleencare.

Hydromer may also terminate this Agreement if Kleencare commits a material
breach and such breach is not cured after a 30 day notice is sent to Kleencare
by Hydromer.

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-5
================================================================================

Kleencare shall have the right to terminate this Agreement before December 31,
2002 for any reason upon a the payment of US$100,000 to Hydromer. Afterwards,
Kleencare may terminate this Agreement by the a 90 day written notice to
Hydromer.

11. EFFECT OF TERMINATION

Upon termination of this agreement Kleencare agrees to immediately discontinue
all use of the Marks and any term similar to the Marks. Kleencare agrees to
delete the similar term or Mark from its corporate or business name, to
cooperate with Hydromer or its appointed agent to apply to the appropriate
authorities to cancel recording of this agreement from all governmental records,
and to destroy all printed material bearing any of the Marks. Kleencare agrees
that all rights in the Marks and the goodwill connected with those Marks shall
remain the property of Hydromer.

As an exception to the previous paragraph Kleencare shall have 90 days to
liquidate the then existing inventory of T-HEXX Teat Dip which comply with all
the standards in this Agreement including but not limited to testing and
releasing.

12. SUPPLY OF T-HEXX CONCENTRATE

HYDROMER will make the patented T-HEXX 12% concentrate available to Kleencare at
US$____ per kg., NOT INCLUDING USE FEES, in minimum orders of 1000 kg., FOB
Branchburg, NJ, USA.

Hydromer reserves the right to increase the price at a rate not to exceed the
increase in the CPI for Northern New Jersey with October 1, 2000 being the base.
Hydromer will give Kleencare a 60 day written notice of any increase. In the
event that the cost increase ratio of any raw material which Hydromer purchases
exceeds the CPI for Northern New Jersey, Hydromer may pass this additional
incremental cost to Kleencare.

All invoices from Hydromer to Kleencare must be paid in 60 days time being of
the essence. If Kleencare fails to pay an invoice in 90 days from the receipt of
an invoice, such omission is a material breach of this Agreement.

13. PATENT LICENSE TO USE.

Kleencare recognizes and agrees that the T-Hexx concentrate formula uses art
taught by patents 4,642,267; 4,769,013 and other patents and patent applications
that are now in existence or will be in existence in any country throughout the
world. Nothing herein is intended to grant a license to make, sell, offer for
sale or import any chemical or concentrate covered by any Hydromer

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-6
================================================================================

patents, patent applications or trade secrets, but only the exclusive right to
use T-Hexx concentrate to make the goods set forth in Exhibit B and selling the
goods with the Marks set forth in Exhibit A.

14. INDEMNIFICATION AND INSURANCE

Kleencare indemnifies Hydromer from all damages resulting from Kleencare's
products or services. Kleencare agrees that it will obtain, at its own expense,
product liability insurance from a recognized insurance company, providing
adequate protection (at least in the amount of US$5,000,000/$10,000,000),
against any claims, suits, loss, and damage (including reasonable attorneys'
fees arising out of any alleged defects in the goods and services listed in
Exhibit B.

As proof of such insurance, a fully paid certificate of insurance will be
submitted to Hydromer by Kleencare for Hydromer's prior approval before any of
the goods and services listed in Exhibit B are distributed or sold, and at the
latest within thirty (30) days after the commencement of the term of this
agreement. Any proposed change in certificates of insurance shall be submitted
to Hydromer for its prior approval. Hydromer shall be entitled to a copy of the
then prevailing certificate of insurance, which shall be furnished to Hydromer
by Kleencare.

15. FORCE MAJEURE

If either party shall be prevented from performing its obligations due to an act
or omission of a government within the territory or an "act of god" they shall
be excused from such performance while such act or omission is in effect and for
1 day thereafter. This paragraph cannot be invoked by Kleencare if any
submission by Kleencare to a government or a governmental agency regarding
T-HEXX finished products is incomplete or inaccurate.

16. GENERAL PROVISIONS

         a. Assignment

         This agreement shall be binding upon the parties' respective successors
         and permitted assignees. Kleencare may not assign this agreement or any
         rights or obligations under this agreement without the prior written
         consent of Hydromer, and any such attempted assignment shall be void. A
         change of control of Kleencare is considered to be an assignment.

         b. Entire Agreement

         This agreement contains the entire understanding of the parties and

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-7
================================================================================

         supersedes all prior written or verbal agreements or representations.
         No change or waiver of any provision of this agreement shall be valid
         unless in writing and signed by the party against whom such change or
         waiver is sought to be enforced. Any signing by Hydromer, Inc. must be
         done by the President of the corporation. No employee, agent, or
         representative of either party has authority to bind such party by any
         oral representation or warranty.

         c. Not a franchise

         The parties agree that this Agreement shall not be considered a
         franchise and any provision of any state law to the contrary is hereby
         waived by both parties to the maximum extent allowed by law.

         d. Surviving Clauses.

         If a court deems or declares invalid or unenforceable any clause or
         provision of this agreement, all other terms and provisions shall
         remain in full force and effect.

         e. Waiver

         No delay or omission by Hydromer to exercise any right or power under
         this agreement shall impair any such right or power or be construed as
         a waiver.

         f. Controlling Law and Place of Suit

         This agreement shall be subject to and shall be interpreted according
         to the laws of the New Jersey and both parties agree to the
         jurisdiction thereof. The United Nations Convention on Contracts for
         the International Sale of Goods and any other like law, statute or
         convention is explicitly disclaimed by both parties.

         The parties have executed this agreement in duplicate by their
respective authorized representatives.

Hydromer, Inc.

By: /s/ Manfred F. Dyck
   --------------------------

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-8
================================================================================

      Manfred F. Dyck

Title:President and CEO

LHS Holding Company on behalf of LHS Limited and Kleencare

BY:
   ----------------------------

TITLE:
      ----------------

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                         Page-9
================================================================================

Exhibit A

                                            T-HEXX(R)ORO

Exhibit B

Licensed for use on the following goods:

Polymeric Film Former for Teats of Fresh Cows ("in milk").

Exhibit C

T-HEXX" ORO Dip FORMULATION

Exhibit C

T-HEXX" ORO Dip Manufacturing Specifications

Exhibit C

T-HEXX" ORO Acceptance Test Parameters

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                        Page-10
================================================================================

Exhibit D

(use fees)

US$_____ per Kg. of T-Hexx 12% concentrate purchased by Kleencare in addition to
the standard price. All purchase of T-Hexx concentrate from Hydromer shall be on
non cancelable purchase order for a minimum quantity of 1000 kg with at least a
3 week notice, Kleencare to supply (or pay of) containers/drums. Hydromer shall
supply and affix T-Hexx labels on the containers of concentrate.

Minimum quarterly purchases shall be:

1/1/2001-3/31/2001                                            1,000 Kg.

4/1/2001-6/30/2001                                            1,000 Kg.

7/1/2001-9/30/2001                                            1,000 Kg.

10/1/2001-12/31/2001                                                  1,000 Kg.

1/1/2002-3/31/2002                                            2,000 Kg.

4/1/2002-6/30/2002                                            2,000 Kg.

7/1/2002-9/30/2002                                            2,000 Kg.

10/1/2002-12/31/2002                                                  2,000 Kg.

1/1/2003-3/31/2003                                            5,000 Kg.

4/1/2003-6/30/2003                                            5,000 Kg.

7/1/2003-9/30/2003                                            5,000 Kg.

10/1/2003-12/31/2003                                                  5,000 Kg.

and for each quarter
         thereafter                                                   5,000 Kg.

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                        Page-11
================================================================================

Exhibit E

Label Guidelines

Guidelines on Use of T-Hexx Trademark and the design of Product Labels

____ Do follow the first prominent use of the mark with a ". Its OK to put " or
tm after each use thereafter but its not necessary.

____ Use the trademark as an adjective, not as a noun. Avoid such use as "put
T-HEXX tm on the teat", say "put T-HEXX tm solution on the teat"

____ Don't confuse a trade mark with a tradename. Hydromer", Inc. is improper as
the word Hydromer is being used to identify the Company. Conversely, Hydromer"
cow teat dip would be identifying the PRODUCT as to its source. Then Hydromer is
being used as a trademark.

____ Do give credit to all the trademarks of on the label. Example "Dermaseal"
is a trademark of Hydromer, Inc."

____ Do not place unknown trademarks on a label. International graphics are in
the public domain but each trademark on a label must be justified as to owner.

____ Don't string trademarks together. It confuses the consumer or buyer as to
the source. Example of stringed trademarks "Fargo" T-Hexx tm teat dip"

____ On T-Hexx labels which represent a custom label for a distributor, the
distributor's trademark should not exceed 150% of the size of the T-HEXX mark .
A distribution trademark should never appear as if the source is the
distributor.

____ Don't makeup or create trademarks. Before using a trademark it must be
searched. A search generally runs US$250-$500 per class plus attorney's fees and
takes 1-2 weeks for a comprehensive search in the USA. Foreign trademarks
searches can run US$500 per country plus fees. Each distributor must use its own
attorney for an opinion.

____ Avoid using the mark generically. Example. "T-Hexx that cow". The solution
may not be T-Hexx.

____ Have a legal review of a printers' proof of the label. Hydromer's legal
department MUST see the printer's proof before any labels are printed.
Turnaround will no more then 48 hours and generally 4 hours or less from receipt
of print proof (not a fax). Ask the printer for two proofs.

<PAGE>

T-HEXX" LICENSE and USE AGREEMENT                                        Page-12
================================================================================

____ A label must have contamination warnings, must display the active
ingredients and the FDA labeler code if assigned.

ADVERTISING GUIDELINES:

Exhibit F

Reporting Form (A substitute to this form is permitted AS LONG AS the reporting
form contains the same data)

Batch Form (include with batch form a sample label to be used on the containers
filled with goods from this batch.)

Batch #  Product Made  Date Made  Ph  SPG  Visc  Bio  Color  %Actives
------   ------------  --------   --  ---  ----  ---  -----  -------<PAGE>

                           KNOW-HOW LICENSE AGREEMENT
                           --------------------------

     This agreement ("Agreement"), having an Effective Date of _______________,
2001, is by and between Hydromer, Inc., a New Jersey corporation, having a place
of business at 35 Industrial Parkway, Branchburg, New Jersey 08876 ("Licensor"),
and Tyco Healthcare Group LP, a Delaware limited partnership, having a place of
business at 15 Hampshire Street, Mansfield, Massachusetts 02048 ("Licensee").
Licensor and Licensee may at times be referred to individually as a Party or
collectively as the Parties.

     WHEREAS, Licensor has developed and owns certain information, know-how,
trade secrets, inventions and data relating to coatings for medical products,
including urology products ("Know-How," as defined below);

     WHEREAS, Licensee manufactures, markets and sells certain medical products,
including urology products;

     WHEREAS, Licensor and Licensee are parties to a Coating Services Agreement
dated as of ________________ ___, 2001, pursuant to which Licensor will perform
certain services using its proprietary Know-How in connection with the
application of Licensor's Coating (as defined below) to certain of Licensee's
urology products;

     WHEREAS, Licensee desires to acquire a license to use the Know-How in
connection with certain of its urology products, and Licensor is willing to
grant a license under suitable conditions as set forth herein.

     NOW, THEREFORE, in consideration of the premises and the mutual covenants
herein contained, and other valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Parties, intending to be legally bound,
agree as follows:

1.   DEFINITIONS

     (a) "Affiliate" shall mean any individual, corporation, liability company,
partnership, association, trust or any other entity or organization directly or
indirectly controlling, controlled by, or under common control with, Licensee.
For purposes of this definition, one entity shall be deemed to control another
entity only if the first entity owns, directly or indirectly, more than fifty
percent (50%) of the outstanding voting equity of another company.

     (b) "Coating" shall mean the coating composition defined as the "Primer"
used to

                                       1
<PAGE>

allow a hydrophilic coating to be attached to silicone polymer surfaces (for
example: silicone Foley catheters used for urinary drainage; silicone balloons,
silicone components used for urinary drainage in connection with a Foley
catheter). The Primer formulation is specifically defined
_________________________

     (c) "Effective Date" shall mean the date first written above.

     (d) "Know-How" shall mean all confidential or proprietary information,
inventions, know-how, trade secrets, and data relating to the Coating relative
to the Licensed Products, including, but not limited to, materials, ingredients,
formulations, processes, methods, manufacturing technology, and performance
characteristics, which Licensor has heretofore developed or acquired, or may
hereafter develop or acquire, and possess at any time during the Term (as
defined below) of this Agreement. The Parties agree that certain of the
Know-How, sufficient in detail to provide for the manufacture and application of
a coating comparable in quality and performance to the Coating licensed
hereunder, shall be deposited in Escrow pursuant to Article 14.

     (e) "Net Sales" shall mean gross sales of the Licensed Products (as defined
below) less ordinary trade quantity discounts, cash discounts, promotional
allowances and returns actually taken.

     (f) "Licensed Products" shall mean _______________________BUT EXCLUDING ANY
__________________ AS SET FORTH IN  EXHIBIT A ATTACHED HERETO.

     (g)"Term" shall have the meaning set forth in Section 3.(g)

     (h) "Territory" shall mean the world.

     (i) "Validation" shall mean the pre-determined criteria and test methods by
which to establish repeatable coating manufacturing processes at Licensor's
facility. Validation will be documented in the form of a protocol. The
Validation protocol will be developed and approved by Licensor and reviewed for
comment by Licensee. Licensor will take responsibility for executing the
Validation. Validation involves and is specific to the Primer and topcoat
coating processes. Validation will not involve the Tyco-supplied ______________,
the independent ___________material or the independent packaging components.

     (j) "Manual Dipping Process" shall mean ______________

                                       2
<PAGE>

     2. LICENSE GRANT

     (a) Licensor hereby grants to Licensee and Licensee hereby accepts from
Licensor, a royalty-bearing, exclusive right and license to use the Know-How in
connection with the manufacture, use, distribution, and sale of Licensed
Products during the Term in the Territory.

     (b) The exclusive license granted to Licensee shall include the right to
grant sublicenses to any other licensee that may be authorized by Licensee,
provided such licensees agree to be bound by all the terms of this Agreement.
Licensee shall guarantee the performance of all sub-licensees.

     (c) The exclusive license granted to Licensee shall become fully paid-up
with no further payments of any kind due Licensor in the event that the Know-How
enters the public domain through no fault of Licensee. Any and all payment
obligations shall terminate on the date of entry of the Know-How into the public
domain, and any payments paid to Licensor by Licensee after the date of entry
shall be refunded to Licensee.

3.   TERM

     The Term of this Agreement shall commence on the Effective Date and shall
terminate on June 4, 2006 unless earlier terminated pursuant to the provisions
of Section 10 of this Agreement. This Agreement shall then self-renew for
successive one year periods beginning June 5, 2006, unless either Party notifies
the other in writing to the contrary on or before the preceding March 4.

4.   ROYALTIES,  PAYMENTS

     (a) In consideration of the rights hereby granted to Licensee in this
Agreement, Licensee agrees to pay Licensor a license fee of fifty thousand
dollars ($50,000.00) payable upon execution of this Agreement. A second license
fee of seventy-five thousand dollars ($75,000.00) will be made to Licensor if
Validation of the Manual Dipping Process is completed no later than 20 weeks
after appropriate payment by Licensee to Licensor of funds (as set forth in (b)
below) to develop the Validation and acquire the equipment necessary to assemble
the Manual Dipping Process as more fully set forth in the definitions above. If
Validation is not completed in this time period then the second license fee of
seventy-five thousand dollars ($75,000.00) shall be reduced to fifty thousand
dollars ($50,000.00) and shall be payable to Licensor upon completion of the
Validation.

                                       3
<PAGE>

     (b) Licensee shall pay to Licensor a one time fee of twenty thousand
dollars ($20,000.00) prior to Licensor starting the Validation, and Licensee
shall pay to Licensor a one time fee of one hundred thousand dollars
($100,000.00) prior to Licensor starting the design and installation of the
Manual Dipping Process. The unit processing costs of $___ per unit of coated
catheter for validation and qualification will be paid by Licensor.

     (c) For each bi-annual period of Year 1 (as defined below) of this
Agreement, Licensee shall pay to Licensor earned royalties in an amount that is
the greater of $20,000 ("Year 1 Bi-Annual Minimum") or two percent (2%) of the
Net Sales of Licensed Products sold by Licensee or its sublicensees ("Net Sales
Royalty").

     (d) For each bi-annual period of Year 2 of this Agreement, Licensee shall
pay to Licensor earned royalties in an amount that is the greater of $30,000
("Year 2 Bi-Annual Minimum") or two percent (2%) of the Net Sales of Licensed
Products sold by Licensee or its sublicensees (Net Sales Royalty").

     (e) For each bi-annual period of Year 3 and of succeeding years of this
Agreement, Licensee shall pay to Licensor earned royalties in an amount that is
the greater of $40,000 ("Year 3+ Bi-Annual Minimum") or two percent (2%) of the
Net Sales of Licensed Products sold by Licensee or its sublicensees (Net Sales
Royalty").

     (f) The first bi-annual period (beginning of Year 1) of this Agreement
shall commence on the earlier of January 1, 2002 or the first day of the
calendar month in which the first commercial sale of Licensed Products by
Licensee or its sub licensees occurs.

     (g) Royalty payments shall be due on or before the forty-fifth (45th) day
following the end of each bi-annual period of this Agreement in which the
applicable sales of Licensed Products occurred, time being of the essence.

     (h) Licensee shall submit to Licensor with every remittance of royalty
payment hereunder a report stating the total value of all Net Sales of Licensed
Products made during the preceding bi-annual period and the amount of royalty
payment due. Licensee shall maintain adequate books of account on which to base
said report and royalty payment during the Term and for a period of two (2)
years following termination or expiration of this Agreement.

     (i) Licensee, upon reasonable notice by Licensor to Licensee and during
normal business hours, shall allow an independent auditor to examine the books
and records to determine the accuracy of the royalty payments. If there is a
five percent (5%) or more shortage in royalty payments, Licensee shall bear the
cost of that portion of the audit in which the discrepancy is found, else the
cost of any audit shall be borne by Licensor

                                       4
<PAGE>

5.   OWNERSHIP OF RIGHTS

     (a) It is understood and agreed that, as between Licensor and Licensee,
Licensor is the sole and exclusive owner of all right, title and interest in and
to the Know-How.

     (b) Nothing contained in this Agreement shall be construed as a sale,
assignment or other transfer to Licensee of any right, title or interest in and
to the Know-How, it being understood that all right, title and interest relating
thereto are expressly retained by Licensor except for the rights being licensed
hereunder.

6.   REPRESENTATIONS, WARRANTIES

     (a) Licensor represents and warrants that, as of the Effective Date, there
are no outstanding agreements, assignments or encumbrances inconsistent with any
provision of this Agreement and that the execution and delivery of this
Agreement by Licensor and the exercise of the rights granted to Licensee under
this Agreement have not resulted, do not result, and to the best of Licensor's
knowledge, will not foreseeably result in the infringement of any intellectual
property rights, including issued patents and published patent applications, of
third parties existing as of the Effective Date. Licensor further represents and
warrants that it is not aware of any adverse action, including patent
infringement suits or asserted patent infringement claims, pertaining to the
subject matter of this Agreement as of the Effective Date.

     (b) Licensor represents and warrants that it has no obligations to third
parties in conflict with any of the provisions hereof. Licensor shall not assume
obligations to third parties in conflict with any of the provisions hereof.

7.   INDEMNIFICATION

     (a) Each Party shall indemnify and hold harmless the other Party from and
against all losses, claims, damages, liabilities, demands, proceedings and costs
(including reasonable legal costs incident thereto) ("Damages") relating to or
arising out of a breach of this Agreement by the indemnifying Party, except to
the extent such Damages are the result of or are caused by the negligence of the
indemnified Party. Each Party will maintain adequate insurance to cover any such
Damages.

     (b) Licensee shall indemnify and hold harmless Licensor from and against
all claims

                                       5
<PAGE>

of third parties relating to the use of Licensed Products, unless such claims
relate to a defect in the Licensed Products which arises or results from
defective Coatings, or in the event Section 14 (b) is in effect, unless such
claims relate to a defect in the Licensed Products which arises or results from
defective Coatings applied properly by Licensee or a third party pursuant to
directions then in effect as supplied by Licensor and/or Escrow Agent, or unless
a court of competent jurisdiction finds that the Licensor has been grossly
negligent and such negligence is proven to be casually connected to the claimed
damages by clear and convincing evidence.

     (c) Licensor shall indemnify and hold harmless Licensee from and against
all claims of third parties relating to any claim of infringement of the
intellectual property rights of such third parties in connection with the
manufacture, use or sale of the Coating relative to the Licensed Products.

     (d) These indemnification obligations shall survive the expiration or
termination of this Agreement.

8.   MISAPPROPRIATION OF KNOW-HOW

     (a) Each Party shall use reasonable efforts to cooperate in the protection
of the Know-How and shall promptly notify the other of any unauthorized use or
misappropriation of any Know-How by a third party after such unauthorized use or
misappropriation comes to that Party's attention.

     (b) In the event that any such third party unauthorized use or
misappropriation of the Know-How relates to the Licensed Products and Licensee
reasonably deems such unauthorized use or misappropriation to be harmful to its
rights granted hereunder, provided that any unauthorized use or misappropriation
shall not be caused by fault, action, or inaction of Licensee, then Licensor,
upon notification by Licensee that Licensee is deemed harmed, shall at its sole
expense bring or cause to be brought against such third party, a lawsuit, action
or proceeding for the unauthorized use or misappropriation of the Know-How.
Licensee agrees to use reasonable efforts to assist in any such lawsuit, action
or proceeding brought by Licensor. Licensor agrees to join Licensee as a party
in any such lawsuit, action or proceeding upon the request of Licensee. Licensor
shall not enter into any settlements that would effect any of Licensee's
licensed rights or royalty obligations without the prior written consent of
Licensee.

     (c) Licensee may, in its sole discretion and at its sole expense, bring or
cause to be brought against such third party, a lawsuit, action, or proceeding
for unauthorized use or

                                       6
<PAGE>

misappropriation of any Know-How in connection with the Licensed Products.
Licensee shall have the right to effect settlements in any such lawsuit, action
or proceeding. Although this Agreement contemplates that Licensee shall have the
right to bring such a lawsuit, action or proceeding in Licensee's own name,
provided that any unauthorized use or misappropriation shall not be caused by
fault, action, or inaction of Licensee, Licensor agrees to to take all steps
necessary including joining any such lawsuit, action or proceeding as a party or
executing a limited field assignment of the Know-How if necessary for standing.
Licensor agrees to use reasonable efforts to assist in any such lawsuit, action
or proceeding brought by Licensee. Licensor agrees not to take any action or
position, in relation to any such lawsuit, action or proceeding, which is
adverse to Licensee's interests under this Agreement.

     (d) In the event Licensor brings a lawsuit, action or proceeding pursuant
to Section 8(b) and Licensee is not joined as a party, then any monetary damages
recovered by Licensor shall belong to Licensor; provided, however, that to the
extent Licensor receives such monetary damages Licensor shall reimburse Licensee
for any reasonable out-of-pocket expenses (not in excess of the amount of such
damages recovered) incurred by Licensee in assisting Licensor in accordance with
Section 8(b). Any monetary damages recovered by Licensee in accordance with
Section 8(c) shall belong to Licensee, provided, however, that to the extent
Licensee receives such monetary damages Licensee shall reimburse Licensor for
any reasonable out-of-pocket expenses (not in excess of the amount of such
damages recovered) incurred by Licensor in assisting Licensee in accordance with
Section 8(c). In the event both Licensor and Licensee are parties to any
lawsuit, action or proceeding for unauthorized use or misappropriation of the
Know-How, any monetary damages recovered shall be distributed as follows: costs
and expenses of each party, with the party instituting the lawsuit, action or
proceeding being reimbursed first; royalties owed to Licensor by Licensee in
order to bring Licensor to the level otherwise paid by Licensee as an exclusive
licensee; royalties owed to Licensor from the infringing sales, which shall be
paid at the rate set forth in Section 4(c), (d) and/or (e); and any remainder to
Licensee.

     (e) In the event any such lawsuit, action or proceeding is brought or
caused to be brought against a third party for unauthorized use or
misappropriation of the Know-How, whether such lawsuit, action or proceeding is
brought pursuant to Section 8(b) or 8(c), the royalties due to Licensor by
Licensee under Section 4(c), (d) and/or (e) shall be reduced by one-half, until
the lawsuit, action or proceeding is concluded or otherwise terminated. Such a
reduction shall be deemed superior expenses to be repaid through any damages
awarded.

                                       7
<PAGE>

9.   ASSIGNABILITY

     (a) Except as provided in Section 2(b), neither Party shall assign,
transfer or otherwise dispose of this Agreement in whole or in part, or any of
its obligations hereunder, to a third party without the prior written consent of
the other Party.

     (b) Notwithstanding the above, Licensee may, without the consent of
Licensor, (i) assign or transfer all or part of its rights under this Agreement
to an Affiliate, or (ii) in the event of a sale by Licensee of all or
substantially all of the assets of the business related to Licensee's
manufacture and sale of any Licensed Product, assign or transfer to the
purchaser of such assets rights under this Agreement to use the Know-How in
connection with the manufacture, use distribution and sale of such Licensed
Product; provided that in each such case the assignee or transferee agrees in
writing to be bound by all the terms of this Agreement. Where any assignment is
made without the consent of the other Party or is made without assigning all or
substantially all of the assets of the business related to Licensee's
manufacture and sale of any Licensed Product, such assignment shall not relieve
the assignor of any of its obligations under this Agreement.

10.  BREACH AND TERMINATION

     The following termination rights are in addition to termination rights
provided elsewhere in this Agreement:

     (a) If either Party hereto is in material breach of any of the material
terms and conditions of this Agreement and fails to cure the breach within sixty
(60) days after the date of receipt of written notice from the other Party
advising it of the nature of such breach, or in the case of a breach that cannot
reasonably be expected to be cured within sixty (60) days fails within such time
to use its best efforts and proceed with due diligence to cure such breach, the
Party not in material breach shall have the right to terminate this Agreement
forthwith by written notice to the Party in material breach, provided however if
the breach is caused by the non- payment of royalties then the notice and cure
periods shall be reduced to fifteen (15) days.

     (b) Either Party hereto shall have the right to terminate this Agreement
forthwith by written notice to the other Party in the event that such other
Party shall be adjudicated bankrupt, become insolvent, make any assignment for
the benefit of its creditors, have its assets placed in the hands of a receiver,
file or have filed against it a petition in bankruptcy, or be dissolved or
liquidated.

                                       8
<PAGE>

     (c) Licensee may terminate this Agreement by one hundred eighty (180) days
prior written notice to Licensor.

     (d) Anything herein to the contrary notwithstanding, in the event of
termination of this Agreement, excepting termination by Licensor pursuant to
Section 10(a) or (b) hereof, Licensee may continue to sell any Licensed Products
previously manufactured and on hand at the time of receipt of notice of
termination for a period of twelve (12) months or until the inventory of such
Licensed Products is depleted provided a full accounting of sales and royalties
are made and paid.

     (e) In the event that this Agreement is in full force and effect in twenty
(20) years from the Effective Date, the Agreement shall terminate and the
Know-How licensed herein shall become fully paid-up and perpetual with no
further payment obligations of Licensee.

     (f) Termination of this Agreement pursuant to any of the provisions hereof
shall be without prejudice to any rights which either Party may have against the
other Party hereto.

     (g) In the event that this Agreement or the exclusive license granted
herein terminates for whatever reason, except for termination pursuant to
Section 2(c) or Section 10(e), Licensee shall immediately cease using any and
all Know-How acquired from Licensor, subject to Section 14.

11.  RIGHT OF FIRST REFUSAL

     (a) In the event Licensor files an application for a patent in the United
States or in any foreign patent office covering the Know-How disclosed (if
applicable per Section 14) and licensed to Licensee, and, if any such
application matures into a patent ("Patents"), Licensee shall automatically have
the option to obtain a worldwide, royalty-bearing, exclusive right and license
in and to the Patents in the manufacture, use, distribution and sale of the
Licensed Products in the Territory on the same terms and conditions (where
applicable), including royalty rates, as negotiated in this Agreement. The
Parties recognize that a separate written agreement covering such an exclusive
license will be required, with any applicable terms and conditions, including
royalty rates, being the same as in this Agreement. The Parties acknowledge that
in any such license or agreement with respect to the Patents, no license fees
shall be due to Licensor from Licensee.

                                       9
<PAGE>

     (b) In the event that Licensee chooses not to exercise its option to obtain
a worldwide, royalty-bearing, exclusive right and license in and to the Patents
in the manufacture, use, distribution and sale of the Licensed Products,
Licensee and Licensor shall negotiate in good faith a worldwide, non-exclusive
right and license in and to the Patents in the manufacture, use, distribution
and sale of the Licensed Products in the Territory for the duration of the Term
of this Agreement.

12.  FUTURE DEVELOPMENTS

     (a) Licensor shall disclose to Licensee (or Escrow Agent as the case may
be) and provide Licensee with access to all improvements of the Know-How
("Improvements") relating to the Coating as applicable to the Licensed Products
which are invented, developed, or otherwise acquired by Licensor during the Term
of this Agreement. Licensee shall automatically have, subject to all the terms
and conditions of this Agreement but without additional royalty, the right to an
exclusive license to use such Improvements in the Territory, including the right
to grant sublicenses.

     (b) In the event Licensor files an application for a patent in the United
States or in any foreign patent office covering the Improvements, and, if any
such application matures into a patent ("Improvement Patents"), Licensee shall
have the option to obtain a worldwide, royalty-bearing, exclusive right and
license in and to the Improvement Patents in the manufacture, use, distribution
and sale of the Licensed Products in the Territory on the same terms and
conditions (where applicable), including royalty rates, as negotiated in this
Agreement. The Parties recognize that a separate written agreement covering such
an exclusive license will be required, with any applicable terms and conditions,
including royalty rates, being the same as in this Agreement. The Parties
acknowledge that in any such license or agreement with respect to the
Improvement Patents, no license fees shall be due to Licensor from Licensee.

     (c) In the event that Licensee chooses not to exercise its option to obtain
a worldwide, royalty-bearing, exclusive right and license in and to the
Improvement Patents in the manufacture, use, distribution and sale of the
Licensed Products, Licensee and Licensor shall negotiate in good faith a
worldwide, non-exclusive right and license in and to the Improvement Patents in
the manufacture, use, distribution and sale of the Licensed Products in the
Territory. The Parties recognize that a separate written agreement covering such
a non-exclusive license will be required.

13.  PRODUCT TESTING AND COMPLIANCE

                                       10
<PAGE>

     At Licensee's request and cost, Licensor shall aid and assist Licensee in
the following:

     (a) Conducting laboratory and clinical evaluations of the Licensed Products
coated with the Coating;

     (b) Preparing accurate labeling and advertising for the Licensed Products
as those terms are defined in the Federal Food, Drug and Cosmetic Act;

     (c) Securing the approval of any state or federal regulatory agency from
which approval may be necessary to commence or continue sales of the Licensed
Products, it being understood and agreed to that any such approval obtained with
respect to the Licensed Products utilizing the Coating shall be the property of
Licensee, it being further understood and agreed to that in the course of
assisting Licensee with obtaining such approval, Licensor may be called upon to,
and shall, disclose in confidence to such regulatory agency the Know-How; and

     (d) Defending the Licensed Products before any state or federal regulatory
agency, which may seek to seize, ban or prevent the introduction of the Licensed
Products into commerce.

     It is understood and agreed to by the Parties that the foregoing aid and
assistance shall not be financial but shall be given by way of review of
protocols, materials and data, personal consultations, preparation of written
statements and oral testimony, and Licensee shall have the sole and exclusive
right to use or disclose any information and data applicable to the Licensed
Products resulting from such aid and assistance. Licensee shall reimburse
Licensor for all reasonable out-of-pocket expenses, which Licensor may incur by
reason of the foregoing. Notwithstanding anything herein to the contrary,
Licensee shall have the responsibility for obtaining any required FDA approval
for the marketing of the Licensed Products. Licensor shall have exclusive rights
to any and all information and data provided and/or generated by Licensor in
rendering such aid as such information and data pertain to all other products
and processes except Licensed Products.

14.  ESCROW / COATING SUPPLY

     (a) Within thirty (30) days from the Effective Date, Licensor shall send to
a third party mutually agreed upon by the Parties ("Escrow Agent'), for
placement in escrow a written statement, together with copies of relevant lab
notebook pages, reflecting the composition of the Coating, the manufacturing
methods thereof, and the coating techniques as they relate to the Licensed
Products ("Documentation"). Every six (6) months thereafter, Licensor shall send
to

                                       11
<PAGE>

the Escrow Agent any updates with respect to the Documentation and if none, a
statement confirming that no updates have occurred. The Escrow Agent shall
notify Licensee that such updates or statement has been received. The
Documentation shall be of sufficient detail to provide for the manufacture of a
coating comparable in quality and performance to the Coating licensed under this
Agreement and shall also provide for coating techniques comparable to those
employed by Licensor. The Escrow Agent shall hold all of the Documentation in
confidence, except that, in the event Licensor is unable to supply Licensee with
the Coating pursuant to Section 14(b) below, Licensor agrees to waive the
obligation of confidence of the Escrow Agent as to Licensee with respect to the
Documentation. In any such event of termination by Licensee, the Escrow Agent
shall, upon receipt of a written request from Licensee, deliver the originals
and all copies of the Documentation to Licensee for use by Licensee or a third
party selected by Licensee in connection with the rights and licenses granted to
Licensee hereunder.

     b) In the event this Agreement is terminated by Licensee pursuant to
Section 10(a) or (b) or is terminated by Licensee pursuant to Section 11 of the
Coating Services Agreement, Licensor shall use its best efforts to supply
Licensee with the Coating at $_____ per gallon in minimum 55 gallon quantities
ordered by Licensee on non-cancelable purchase orders and on terms that are no
more burdensome then the terms of this Agreement. Licensor may raise this price
no more than once per contract year limited to the same percentage increase as
the Cost of Living Indicator for Northern New Jersey ("COL"), provided however,
if raw material prices are increased by suppliers to Licensor greater than said
COL, Licensor may pass on the greater costs over the COL to Licensee. This
Section 14(b) is subject to the Coating meeting Licensor's manufacturing and
quality assurance specifications _________________________ Further, Section
14(b) shall not apply if Licensor is unable to supply Licensee within 60 days of
termination by Licensee.

     (c) In the event Licensor is unable to supply Licensee with the Coating
pursuant to Section 14(b) but subsequently offers to supply the Coating to
Licensee, Licensee shall then order the Coating from Licensor, provided Licensor
notifies Licensee in writing of said offer at least two (2) years in advance of
the date of supply and further provided Licensor agrees to reimburse Licensee
for any non-amortized equipment costs and expenses. . This Section 14(c) is
subject to the Coating meeting Licensor's manufacturing and quality assurance
specifications therefor, as set forth _______________________________________

     (d) Royalties for sales under Section 14(a), (b) or (c) shall be paid
pursuant to the terms set forth in Section 4(c), (d) or (e). Any costs in excess
of what would have been paid by Licensee to Licensor which are incurred by
Licensee as a result of Licensor's inability to supply

                                       12
<PAGE>

Licensee with the Coating will be deducted from future royalty payments owed to
Licensor under the terms of this Agreement.

15.  CONFIDENTIAL INFORMATION

     Licensor and Licensee agree to use reasonable efforts to maintain in strict
confidence, and not to disclose to others, any technical or financial
information they obtain from each other pursuant to this Agreement relating to
the manufacture, distribution and sale of the Licensed Products (hereinafter
"Confidential Information"). Information disclosed by either Party shall not be
Confidential Information to the extent that such information (a) is available to
members of the public or becomes publicly available through no unauthorized act
of the receiving Party, (b) is subsequently given to the receiving Party by a
third party having a right to do so, or (c) is independently developed by
employees of the receiving Party, as evidenced by written documents in its
possession. Each Party's obligation not to disclose the Confidential Information
shall run for a period of three (3) years from the termination or expiration of
this Agreement. Such obligation of confidentiality shall not apply to the extent
that either Party is required to disclose such Confidential Information to the
government or makes use of such Confidential Information in any dispute with the
other Party over the terms or performance of this Agreement in any court of law
or equity and then only under a protective order of the court.

16.  NO JOINT VENTURE

     Nothing herein contained shall be construed to place the Parties in the
relationship of partners or joint venturers, and neither Licensee nor Licensor
shall become bound by any representation, act or omission of the other.

17.  WAIVERS

     None of the terms of this Agreement can be waived or modified except by an
express agreement in writing signed by all the Parties hereto. There are no
representations, promises, warranties, covenants or undertakings other than
those contained in this Agreement, which represents the entire understanding of
the Parties. The failure of any Party to enforce, or the delay by any Party in
enforcing, any of its rights under this Agreement shall not be deemed a
continuing waiver or a modification thereof and any Party may, within the time
provided by applicable law, commence appropriate legal proceedings to enforce
any and all such rights.

18.  SEVERABILITY

                                       13
<PAGE>

     In the event that any term or provision of this Agreement shall for any
reason be held to be invalid, illegal or unenforceable in any respect, such
invalidity, illegality or unenforceability shall not affect any other term or
provision and this Agreement shall be interpreted and construed as if such term
or provision, to the extent the same shall have been held to be invalid, illegal
or unenforceable, had never been contained herein.

19.  INTEGRATION

     This Agreement represents the entire understanding between the Parties
hereto with respect to the subject matter hereof and this Agreement supersedes
all previous representations, understandings or agreements, oral or written,
between the Parties with respect to the subject matter hereof and cannot be
modified except by a written instrument signed by the Parties hereto.

20.  NON ANALYSIS

     Licensee agrees it will not analyze or reverse engineer the Coating, except
in accordance with Sections 2(c), 10(g) and 14(b).

21.  PUBLICITY

     No press release, advertising, promotional statements (either oral or
written) in connection with the existence, substance or details of this
Agreement or the contractual arrangements relating to the subject matter of this
Agreement, shall be made by Licensor unless required by Law without the prior
written approval of the Licensee, which approval shall not be unreasonably
withheld.

22.  NOTICES

     Any notice or other communication required or permitted to be given by the
Parties hereto shall be mailed by registered or certified United States mail,
postage prepaid, and addressed as follows:

                  If to Licensor:
                  Hydromer, Inc.
                  35 Industrial Parkway
                  Branchburg, New Jersey
                  Attention: Vice President and General Counsel

                  If to Licensee:
                  Tyco Healthcare Group LP
                  15 Hampshire Street
                  Mansfield, Massachusetts 02048
                  Attention:  Vice President - Intellectual Property

                                       14
<PAGE>

     Notices or other communications mailed as herein provided shall be deemed
to have been given when received or when an attempt to deliver same was made as
evidenced by a duly executed return receipt.

23.  CAPTIONS

     The captions used in connection with the paragraphs and subparagraphs of
this Agreement are inserted only for purpose of reference. Such captions shall
not be deemed to govern, limit, modify or in any other manner affect the scope,
meaning or intent of the provisions of this Agreement or any part thereof, nor
shall such captions otherwise be given any legal effect.

24.  GOVERNING LAW

     This Agreement shall be governed by and construed in accordance with the
laws of New Jersey, without regard to the conflicts of law principles thereof.

     IN WITNESS WHEREOF, Licensor and Licensee have caused this instrument to be
duly executed as of the day and year first above written.

HYDROMER, INC.                                       TYCO HEALTHCARE GROUP LP

By:                                                  By:
   ------------------------                             ------------------------
Name:                                                Name:
     ----------------------                               ----------------------
Title:                                               Title:
      ---------------------                                ---------------------

Exhibit A     Exclusions of Licensed Products

-----------

                                       15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}]]